Cargando…

RAGE: A novel target for breast cancer growth and metastasis

Detalles Bibliográficos
Autores principales:	Nasser, Mohd W., Ahirwar, Dinesh K., Ganju, Ramesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789569/ https://www.ncbi.nlm.nih.gov/pubmed/27014721

Ejemplares similares

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
por: Wani, Nissar Ahmad, et al.
Publicado: (2014)

Editorial: Inflammation and Myeloid Cells in Cancer Progression and Metastasis
por: Mishra, Sanjay, et al.
Publicado: (2022)

STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade
por: Varikuti, Sanjay, et al.
Publicado: (2017)

Fibroblast-Derived CXCL12 Promotes Breast Cancer Metastasis by Facilitating Tumor Cell Intravasation
por: Ahirwar, Dinesh K., et al.
Publicado: (2018)

Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4
por: Wilkie, Tasha, et al.
Publicado: (2021)

Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
por: Charan, Manish, et al.
Publicado: (2020)

Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
por: Charan, Manish, et al.
Publicado: (2020)

The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
por: Hussain, Shahid, et al.
Publicado: (2020)

Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB(2) in Modulating Breast Cancer Growth and Invasion
por: Nasser, Mohd W., et al.
Publicado: (2011)

Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
por: Mishra, Sanjay, et al.
Publicado: (2021)

Longistatin in tick-saliva targets RAGE
por: Anisuzzaman,, et al.
Publicado: (2015)

miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
por: Zhao, Helong, et al.
Publicado: (2015)

Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
por: Zhao, Helong, et al.
Publicado: (2015)

Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells
por: Varikuti, Sanjay, et al.
Publicado: (2020)

Non-contact method for directing electrotaxis
por: Ahirwar, Dinesh K., et al.
Publicado: (2015)

Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis
por: Ryan, Daniel, et al.
Publicado: (2019)

Electromagnetic fields alter the motility of metastatic breast cancer cells
por: Garg, Ayush Arpit, et al.
Publicado: (2019)

Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
por: Misri, Swati, et al.
Publicado: (2022)

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability
por: Powell, Catherine A., et al.
Publicado: (2015)

Is RAGE the receptor for inflammaging?
por: Frimat, Marie, et al.
Publicado: (2019)

Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages
por: Ahirwar, Dinesh K., et al.
Publicado: (2023)

FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
por: Ravi, Janani, et al.
Publicado: (2014)

RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
por: Faruqui, Tabrez, et al.
Publicado: (2022)

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
por: Magna, Melinda, et al.
Publicado: (2023)

Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility
por: Holter, Jacob C., et al.
Publicado: (2022)

Targeting RAGE in sepsis
por: van Zoelen, Marieke AD, et al.
Publicado: (2008)

Slit2-Mediated Metabolic Reprogramming in Bone Marrow-Derived Macrophages Enhances Antitumor Immunity
por: Kaul, Kirti, et al.
Publicado: (2021)

RAGE at Tumor Microenvironment. Looking at Tumor-associated Macrophages
por: DELGADO-LÓPEZ, Fernando, et al.
Publicado: (2015)

When It Comes to COVID-19, Inflammation Is All the RAGE
por: Katsoulis, Orestis, et al.
Publicado: (2023)

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
por: El-Far, Ali H., et al.
Publicado: (2020)

Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling
por: Pan, Shuo, et al.
Publicado: (2022)

PRAK mediates Aβ-RAGE driven autophagy pathway
por: Kim, Yoonhee, et al.
Publicado: (2017)

RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer
por: Chen, Mei-Chih, et al.
Publicado: (2020)

The COVID-19 pandemic may be receding but the diabetes pandemic rages on
por: Mulder, Hindrik, et al.
Publicado: (2022)

S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation
por: Paruchuri, Vikram, et al.
Publicado: (2008)

Knockdown of RAGE Inhibits Growth and Invasion of Gastric Cancer Cells
por: Xu, X.C., et al.
Publicado: (2013)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy
por: Kanchan, Ranjana K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8nvj0pnh1ammklrtl6qsph8oj1